Can Someone Change Their Mind After Giving Consent?

Does Saying Yes to Research Mean You Have to Finish It?

A participant understood the study, voluntarily agreed to join, and signed the consent form. Several weeks or months later, they decide they no longer want to participate.

Nothing necessarily went wrong. Perhaps the study takes more time than expected. Their circumstances have changed. They dislike a procedure. They have simply reconsidered.

Can someone reverse a decision that was valid when they made it? Yes. Informed consent authorizes voluntary participation; it does not create an obligation to remain in research.

Consent Can Be Withdrawn

Consent Authorizes Participation; It Does Not Lock the Participant In

Voluntariness Continues After Enrollment

The right to decide does not disappear once someone signs a consent form. Under the U.S. Common Rule, informed consent must state that participation is voluntary, refusal carries no penalty or loss of benefits to which the person is otherwise entitled, and the participant may discontinue participation at any time. FDA informed-consent requirements contain the same basic protection for regulated clinical investigations.

International ethical guidance follows the same principle. CIOMS states that prospective participants must be informed that they are free to refuse participation and free to withdraw from research at any time without penalty or loss of benefits to which they would otherwise be entitled.

This is one reason informed consent is better understood as an ongoing process than as a one-time transaction.

The Participant Does Not Need a Reason Researchers Consider Good Enough

A participant may leave because of adverse effects, inconvenience, competing responsibilities, loss of interest, dissatisfaction, anxiety, transportation difficulties, or another concern. They may also simply decide that they no longer want to participate.

ICH Good Clinical Practice states that a participant is not obliged to provide a reason for withdrawing prematurely. Investigators may make a reasonable effort to understand the reason, particularly when it could matter to safety or study conduct, but continuation should not depend on the participant providing an explanation acceptable to the research team.

Changing Your Mind Does Not Mean the Original Consent Was Invalid

A later withdrawal does not prove that the participant's earlier consent was defective. Both decisions can be valid.

A person can voluntarily choose participation in January and voluntarily choose to stop in June. Their preferences, circumstances, understanding of the burden, or tolerance for procedures may change without anything having been wrong with the original decision.

This distinction matters for researchers because withdrawal should not automatically be treated as evidence of consent failure, participant unreliability, or research misconduct.

Find Out What the Participant Actually Wants to Stop

The word withdraw can conceal several different decisions. A participant might want to stop an intervention but remain willing to attend follow-up visits. They might refuse future study visits but permit researchers to collect information already generated through routine care. Or they may want all future research interaction and collection of identifiable private information to stop.

OHRP therefore recommends clarifying whether someone withdrawing from a clinical trial wants to leave all components or only the primary interventional component. If the participant wants only to discontinue the intervention, other research activities for which they previously consented may continue when permitted by the protocol and applicable requirements.

Withdrawal Primarily Changes What Happens Next

If a participant withdraws from all components of HHS-regulated research, OHRP states that investigators must discontinue research interactions and interventions with that participant and stop obtaining additional identifiable private information for that study.

That prospective effect is important. Researchers cannot respond to withdrawal by continuing the same research procedures simply because the participant once agreed to them.

Some orderly termination procedures may nevertheless be appropriate, particularly when stopping an intervention abruptly could create safety concerns. FDA regulations expressly recognize that informed consent may describe the consequences of withdrawal and procedures for orderly termination.

Already Collected Data Are a Separate Question

Participants sometimes understandably assume that withdrawing means everything they previously contributed disappears. That is not universally the case.

OHRP interprets HHS regulations as allowing investigators to retain and analyze data already collected before withdrawal when the analysis remains within the IRB-approved protocol. FDA policy for FDA-regulated clinical trials is stricter: already-accrued data remain part of the trial database and may not be removed.

Other jurisdictions and study types may operate under different legal, consent, privacy, and governance rules. For that reason, what happens to data after withdrawal should be treated as a separate question rather than assumed from the right to stop participating.

Researchers May Ask About Continued Follow-Up, but the Choice Must Remain Voluntary

In some clinical research, follow-up after stopping an intervention is scientifically and medically important. OHRP recommends explaining the importance of follow-up safety data when a participant wishes to stop the primary intervention. FDA likewise recognizes that an investigator may ask whether a withdrawing participant is willing to permit continued follow-up.

That conversation should distinguish clearly between stopping the intervention and agreeing to continued research follow-up. It should not turn into pressure to remain involved.

Changing One's Mind Can Also Mean Changing Only Part of Participation

Participants do not always move from complete participation to complete withdrawal. Sometimes they want to change the nature of their involvement.

Whether a participant can withdraw from only part of a study depends on what they want to stop and whether the approved protocol can accommodate continued participation without that component.

When a Participant Decides the Study Is No Longer Worth the Burden

The participant did not need to demonstrate that the original consent was flawed. They simply exercised the continuing right to decide whether participation remained acceptable.

Common Mistakes About Changing Your Mind After Consent

When Consent Changes, Clarify What the Participant Wants to Change

When someone says they want to stop, your first task is not to persuade them to remain. It is to understand the scope of their decision and implement it appropriately.

When a Participant Changes Their Mind

Questions About Changing Your Mind After Research Consent

A Valid Yes Can Later Become a Valid No

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.